01 3AVELUMAB
02 1CETRORELIX (CETRORELIX ACETATE)
03 2CETRORELIX ACETATE
04 4CHORIOGONADOTROPIN ALFA
05 2CLADRIBINE
06 1CLOMIPHENE CITRATE
07 7FOLLITROPIN ALFA
08 12FOLLITROPIN ALFA/BETA
09 4INTERFERON BETA-1A
10 11LEVOTHYROXINE SODIUM
11 4LUTROPIN ALFA
12 7METFORMIN HYDROCHLORIDE
13 3MITOXANTRONE HYDROCHLORIDE
14 1PROGESTERONE
15 3SERMORELIN ACETATE
16 14SOMATROPIN
17 4SOMATROPIN RECOMBINANT
18 1TEPOTINIB (TEPOTINIB HYDROCHLORIDE)
19 1TEPOTINIB HYDROCHLORIDE
20 1WATER
01 32EMD SERONO
02 15EMD SERONO INC
03 28EMD SERONO, A DIVISION OF EMD INC., CANADA
04 11MERCK KGAA
01 1GEL
02 20INJECTABLE;INJECTION
03 1INJECTABLE;INTRAVENOUS
04 14INJECTABLE;SUBCUTANEOUS
05 6POWDER FOR SOLUTION
06 2POWDER;SUBCUTANEOUS
07 19SOLUTION
08 2TABLET
09 2TABLET, EXTENDED RELEASE;ORAL
10 19TABLET;ORAL
01 10.025MG
02 10.05MG
03 10.075MG
04 10.088MG
05 10.112MG
06 10.125MG
07 10.15MG
08 10.175MG
09 10.1MG
10 20.25MG/VIAL
11 10.2MG
12 10.3MG
13 11,050 IU/VIAL
14 210MG
15 1132MCG/1.5ML
16 1150 IU/0.25ML
17 2150 IU/VIAL
18 1150UNIT/0.48ML
19 11GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
20 11ML/KIT
21 320MG/ML
22 1225MG
23 1225UNIT/0.72ML
24 122MCG/0.5ML
25 2250MCG/0.5ML
26 1300 IU/0.5ML
27 1300UNIT/0.48ML
28 1300UNIT/0.5ML
29 237.5 IU/VIAL
30 144MCG/0.5ML
31 1450 IU/0.75ML
32 1450 IU/VIAL
33 1450UNIT/0.72ML
34 1450UNIT/0.75ML
35 1450UNIT/1.44ML
36 34MG/VIAL
37 15.5MCG/VIAL
38 15.83MG/ML
39 2500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
40 150MG
41 15MG/KIT
42 45MG/VIAL
43 1625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
44 166MCG/1.5ML
45 16MG/0.5ML (6MG/0.5ML)
46 36MG/VIAL
47 275 IU/VIAL
48 2750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
49 175UNIT/VIAL
50 18%
51 38.8MG/VIAL
52 1850MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
53 28MG/ML
54 1900 IU/1.5ML
55 1900UNIT/1.44ML
56 1900UNIT/1.5ML
57 1EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
58 1EQ 0.25MG /0.5ML
59 1EQ 0.25MG BASE/VIAL
60 1EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
61 1EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
62 1EQ 20MG BASE/10ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
63 1EQ 225MG BASE
64 1EQ 25MG BASE/12.5ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
65 1EQ 30MG BASE/15ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
66 1EQ 3MG BASE/VIAL
01 28Canada
02 58USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761049
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 761078
Regulatory Info :
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : BAVENCIO
Dosage Strength : 20MG/ML
Packaging : 10ML VIAL
Approval Date :
Application Number : 2469723
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
CETRORELIX (CETRORELIX ACETATE)
Dosage Form : POWDER FOR SOLUTION
Brand Name : CETROTIDE
Dosage Strength : 0.25MG/VIAL
Packaging : 1ML
Approval Date :
Application Number : 2247766
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 0.25MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : POWDER;SUBCUTANEOUS
Brand Name : CETROTIDE
Dosage Strength : EQ 3MG BASE/VIAL
Packaging :
Approval Date : 2000-08-11
Application Number : 21197
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INJECTION
Brand Name : OVIDREL
Dosage Strength : 0.25MG/VIAL
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;SUBCUTANEOUS
Brand Name : OVIDREL
Dosage Strength : EQ 0.25MG /0.5ML
Packaging :
Approval Date :
Application Number : 21149
Regulatory Info :
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML
Approval Date :
Application Number : 2262088
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Dosage Form : SOLUTION
Brand Name : OVIDREL
Dosage Strength : 250MCG/0.5ML
Packaging : 0.5ML/3ML
Approval Date :
Application Number : 2371588
Regulatory Info : Prescription
Registration Country : Canada
LOOKING FOR A SUPPLIER?
